Which decentralised trial activities are reported in clinical trial protocols of drug trials initiated in 2019–2020? A cross-sectional study in ClinicalTrials.gov

por de Jong, Amos J, Grupstra, Renske J, Santa-Ana-Tellez, Yared, Zuidgeest, Mira G P, de Boer, Anthonius, Gardarsdottir, Helga
Publicado 2022

Stakeholders’ views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs

por Kalkman, Shona, van Thiel, Ghislaine J. M. W., Grobbee, Diederick E., Meinecke, Anna-Katharina, Zuidgeest, Mira G. P., van Delden, Johannes J. M.
Publicado 2016

A cross-sectional survey on the early impact of COVID-19 on the uptake of decentralised trial methods in the conduct of clinical trials

por Suman, Arnela, van Es, Jasmijn, Gardarsdottir, Helga, Grobbee, Diederick E., Hawkins, Kimberly, Heath, Megan A., Mackenzie, Isla S., van Thiel, Ghislaine, Zuidgeest, Mira G. P.
Publicado 2022

Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective

por de Jong, Amos J., van Rijssel, Tessa I., Zuidgeest, Mira G. P., van Thiel, Ghislaine J. M. W., Askin, Scott, Fons‐Martínez, Jaime, De Smedt, Tim, de Boer, Anthonius, Santa‐Ana‐Tellez, Yared, Gardarsdottir, Helga
Publicado 2022

Women in Translational Medicine: Tools to Break the Glass Ceiling

por Bots, Sophie H., Zuidgeest, Mira G. P., Gohar, Aisha, Eikendal, Anouk L. M., Petrelli, Alessandra, van Os-Medendorp, Harmieke, van der Schaaf, Marieke F., van Sorge, Nina M., van Wijk, Myriam, Middendorp, Sabine, Speksnijder, Caroline M., Klipstein-Grobusch, Kerstin, Seyfert-Margolis, Vicky, Mollema, Esther, van Wijk, Femke, den Ruijter, Hester M.
Publicado 2018